A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers
CompletedNCT06889012
Boryung Pharmaceutical Co., LtdEssential Hypertension, Primary Hypercholesterolemia
Start: 2025-05-07End: 2025-07-23Updated: 2025-09-12